Pharmafile Logo

Portcullis Public Affairs

Portcullis Public Affairs is a leading government and communications consultancy, with over 25 years experience offering advice to prominent companies, charities and other organisations in the UK. Health specialisms include public affairs, government relations in the UK and Europe, and crisis management. We help Government reach better decisions. Portcullis is in partnership with MAP BioPharma which helps clients navigate the detailed processes so as to achieve optimal market access in the UK, Ireland and Germany. Together, we provide a unique combination of public affairs capabilities and detailed market analyses.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Visions4Health

Visions4Health are market access experts and your gateway to local adoption at pace. Leveraging our lived experience, understanding of national and local healthcare systems, and insights generated by our stakeholder…

View Profile

Company Details

11 Haymarket, London, SW1Y 4BP, United Kingdom
+44 (0)20 7368 3100

 Latest Content from PMHub 

Highlighting the Power of Patient-Integration

Press Releases | December 2, 2024 | Medscape Education

Advancing person-centered care is an important topic for the Medscape Oncology team, and no one knows this better than Dr Victoria Harvey-Jones, Associate Director of Clinical Strategy for Medscape Oncology...

Seven strategic steps to enhance patient recruitment & retention in your influenza studies

The development of all treatments, including vaccines, is dependent on people taking part in clinical trials but this can be challenging for influenza studies, especially given the typically short patient...

Innovating Differently: A Conversation with David W. Miller, CEO of Genesis Research Group

A recent interview with Dr. David W. Miller, Chairman and CEO of Genesis Research Group, about his vision for the business, the changing face of research, and their unique value proposition...

Education, AI and More at ASH 2024

Press Releases | November 25, 2024 | Medscape Education

Medscape will showcase eight educational symposia and three posters at ASH 2024, highlighting advancements in hematology and oncology education. The presentations will reflect on the impact of last year's programs,...

Innovative Trials celebrates success for its groundbreaking Retention Patch Program

Press Releases | November 22, 2024 | Innovative Trials

Innovative Trials attended the PME Award Gala Dinner last night (21st November 2024)

Genesis Research Group unveils enhanced US market access data analytics

Genesis Research Group (“Genesis”), a pioneer of tech-enabled real-world evidence (RWE), health economics and outcomes research (HEOR), and market access services, announces the expansion of its real-world data analytics capabilities...

Health Awareness V Health Anxiety: Is the increase of online health content a help or hindrance?

White Papers and Resources | November 19, 2024 | Mednet

Medical Writer, Steph Gathercole, looks at the impact increased access to online health information has on the public through the lens of Anxiety

Insights and reflections from the Mtech Access transforming healthcare symposium

Press Releases | November 19, 2024 | Petauri Evidence

Our transforming healthcare symposium was held on Tuesday 5th November 2024. In this article, Prof Phil Richardson (Chief Innovation Officer, Mtech Access) shares his reflections from the day.

EU Joint Clinical Assessment (JCA) – Implications for Pharma and Medtech

Katie Rose (Consultant – Market Access), Maria Dimitrova (Consultant – HTA) and Samantha Gillard (Director – HTA) provide an overview of the EU Joint Clinical Assessment (JCA) and what it...